Switch to:
More From Other Websites
Myriad Validates Active Surveillance Threshold With Prolaris(R) for Men With Prostate Cancer May 15 2015
Myriad Validates Active Surveillance Threshold With Prolaris(R) for Men With Prostate Cancer May 15 2015
Myriad Showcases Its Pioneering Research at the 2015 ASCO Annual Meeting May 13 2015
Myriad Showcases Its Pioneering Research at the 2015 ASCO Annual Meeting May 13 2015
Myriad Genetics Q3 Test Growth Impresses Yet Revenues Fall - Analyst Blog May 11 2015
10-Q for Myriad Genetics, Inc. May 08 2015
Myriad to Present New Clinical Data on Prolaris(R) at the AUA 2015 Annual Meeting May 07 2015
Myriad to Present New Clinical Data on Prolaris(R) at the AUA 2015 Annual Meeting May 07 2015
Myriad Genetics Posts In-Line Q3 Earnings, Guides Lower - Analyst Blog May 06 2015
MYRIAD GENETICS INC Files SEC form 10-Q, Quarterly Report May 06 2015
Myriad Genetics Reports Fiscal Third-Quarter 2015 Financial Results May 05 2015
Myriad meets 3Q profit forecasts May 05 2015
Myriad meets 3Q profit forecasts May 05 2015
Myriad Genetics Inc Earnings Call scheduled for 4:30 pm ET today May 05 2015
MYRIAD GENETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 05 2015
Myriad Genetics Reports Fiscal Third-Quarter 2015 Financial Results May 05 2015
Q3 2015 Myriad Genetics Inc Earnings Release - After Market Close May 05 2015
PDF 11.91 KB May 04 2015
Myriad Genetics Fights Off Threats From Rivals May 03 2015
11 Buyout Targets Credit Suisse Is Watching Apr 29 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Antoniy
ReplyAntoniy - 1 year ago
hs


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK